🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

27 recruiting trials

for Melanoma, Cutaneous Malignant

Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial NCT06965231Phase 24 sites📍 Shanghai📍 Shanghai📍 Shanghai Fudan University · Tests: Toripalimab combined with Endostar IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Bevacizumab, Glutaminase-1 Inhibitor IACS-6274, Paclitaxel, Capivasertib Cryoablation Combined With Hepatic Arterial Infusion of Iparomlimab and Tuvonralimab (QL1706), Intravenous Dacarbazine, and Oral Lenvatinib in Patients With Liver Metastases From Malignant Melanoma: a Single-arm, Phase II, Prospective Trial NCT07847359Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Cryoablation, Iparomlimab and Tuvonralimab, Dacarbazine, Lenvatinib A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases NCT04511013Phase 2331 sites📍 Birmingham📍 Fairhope📍 Mobile SWOG Cancer Research Network · Tests: Binimetinib, Encorafenib, Ipilimumab, Nivolumab Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors NCT04068155NA2 sites📍 Grenoble📍 Lyon Alpha Tau Medical LTD. · Tests: DaRT- Diffusing Alpha-emitters Radiation Therapy Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer NCT03819296Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Best Practice, Biospecimen Collection, Endoscopic Procedure, Fecal Microbiota Transplantation, Infliximab Evaluation of Skin Tests in Biotherapy Allergies NCT06971848NA1 site📍 Angers University Hospital, Angers · Tests: Drug skin tests (investigating hypersensitivity to a biotherapy) Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma NCT03860883NA192 sites📍 Mobile📍 Gilbert📍 Phoenix Melanoma and Skin Cancer Trials Limited · Tests: Wide Local Excision = 1cm Margin, Wide Local Excision = 2cm Margin SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma NCT06743126Phase 371 sites📍 Phoenix📍 Scottsdale📍 Duarte Immatics US, Inc. · Tests: IMA203, nivolumab plus relatlimab, lifileucel, nivolumab, pembrolizumab MRI-Guided Focused Ultrasound Radiosensitization for Patients With Malignant Melanoma and Non Melanoma Skin Cancer NCT05620290Phase 11 site📍 Toronto Sunnybrook Health Sciences Centre · Tests: Definity, Sonalleve Focused Ultrasound Device Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study NCT07215988n/a1 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Non-Interventional Study DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. NCT07440290Phase 2, Phase 327 sites📍 Belfast📍 Birmingham📍 Birmingham Cancer Research UK · Tests: Dabrafenib, Trametinib Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer NCT05098210Phase 11 site📍 Seattle Fred Hutchinson Cancer Center · Tests: Neoantigen Peptide Vaccine, Nivolumab, Poly ICLC, Echocardiography Test, Multigated Acquisition Scan EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial NCT06767332NA2 sites📍 Leiden📍 Leiden Leiden University Medical Center · Tests: eye movement desensitization and reprocessing (EMDR) A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors NCT07070232Phase 1, Phase 277 sites📍 Phoenix📍 San Francisco📍 Hartford BioNTech SE · Tests: BNT326, Pumitamig, Itraconazole, Paroxetine A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents NCT06090266Phase 1, Phase 24 sites📍 Austin📍 Irving📍 San Antonio OncoResponse, Inc. · Tests: OR502, Cemiplimab Registry of Subjects at Risk of Pancreatic Cancer NCT04095195n/a4 sites📍 Rozzano📍 Peschiera del Garda📍 Milan Associazione Italiana per lo Studio del Pancreas · Tests: MRCP, Endoultrasonography A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma NCT03116412NA20 sites📍 Borås📍 Eskilstuna📍 Falun Uppsala University · Tests: CT or PET scans Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors NCT04119024Phase 13 sites📍 Duarte📍 Los Angeles📍 Stanford Anusha Kalbasi · Tests: Biopsy, Biospecimen Collection, Computed Tomography, Cyclophosphamide, Fludarabine Phosphate Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program NCT06265285Phase 21 site📍 Jacksonville Mayo Clinic · Tests: Home Health Encounter, Nivolumab, Patient Monitoring, Questionnaire Administration Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors NCT05269381Phase 1, Phase 21 site📍 Jacksonville Mayo Clinic · Tests: Cyclophosphamide, Neoantigen Peptide Vaccine, Pembrolizumab, Sargramostim, Biospecimen Collection A Beta-only IL-2 ImmunoTherapY Study NCT05086692Phase 1, Phase 228 sites📍 San Diego📍 San Francisco📍 Santa Monica Medicenna Therapeutics, Inc. · Tests: MDNA11, Pembrolizumab (KEYTRUDA®) Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma NCT06488482Phase 326 sites📍 Helsinki📍 Kuopio📍 Tampere Uppsala University · Tests: nivolumab or pembrolizumab Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis NCT07890415Phase 38 sites📍 Stanford📍 Basking Ridge📍 Middletown Memorial Sloan Kettering Cancer Center · Tests: Clinical decision support tool Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types NCT06075524n/a1 site📍 Rochester Mayo Clinic · Tests: Biospecimen Collection, Electronic Health Record Review Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain NCT05588453Phase 1, Phase 21 site📍 Columbus Kari Kendra · Tests: Natural Killer Cell Therapy, Temozolomide Pancreas Registry and High Risk Registry NCT02775461n/a2 sites📍 New York📍 New York Icahn School of Medicine at Mount Sinai
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy